HK Stock MarketDetailed Quotes

ETS GROUP (08031)

Watchlist
  • 0.430
  • -0.005-1.15%
Market Closed May 6 13:00 CST
127.12MMarket Cap-14.83P/E (TTM)

ETS GROUP (08031) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Turnover
-3.56%77.85M
-0.33%42.63M
4.66%80.73M
12.26%42.77M
-10.45%77.13M
-8.14%57.94M
-9.82%38.1M
-13.40%20M
-12.79%86.13M
-17.00%63.08M
Operating income
-3.56%77.85M
-0.33%42.63M
4.66%80.73M
12.26%42.77M
-10.45%77.13M
-8.14%57.94M
-9.82%38.1M
-13.40%20M
-12.79%86.13M
-17.00%63.08M
Operating expenses
Gross profit
Employee expense
5.05%-74.04M
-7.39%-37.97M
-19.06%-77.97M
-7.79%-35.36M
6.37%-65.49M
4.32%-49.34M
5.72%-32.81M
16.08%-16.65M
4.83%-69.95M
6.65%-51.57M
Depreciation and amortization
-1.20%-3.38M
-110.01%-1.76M
-59.25%-3.34M
31.73%-839K
44.69%-2.1M
64.10%-1.76M
62.87%-1.23M
61.61%-645K
59.40%-3.79M
36.47%-4.91M
Special items of operating profit
-189.05%-8.94M
47.90%-1.85M
226.41%10.04M
-1,055.65%-3.56M
61.03%-7.94M
88.94%-427K
117.58%372K
121.55%531K
38.59%-20.37M
75.88%-3.86M
Operating profit
-189.99%-8.5M
-65.59%1.04M
487.99%9.45M
-32.04%3.01M
120.14%1.61M
133.82%6.42M
119.12%4.44M
460.49%3.23M
53.74%-7.98M
192.30%2.74M
Financing cost
51.89%-89K
-408.33%-61K
72.75%-185K
60.00%-12K
37.88%-679K
-314.75%-506K
74.36%-30K
40.43%-28K
-120.36%-1.09M
-1.67%-122K
Earning before tax
-192.75%-8.59M
-67.49%976K
898.28%9.26M
-31.85%3M
110.23%928K
125.40%5.91M
130.99%4.41M
439.55%3.2M
48.88%-9.07M
184.77%2.62M
Tax
103.04%26K
----
-552.67%-855K
28.34%-177K
41.26%-131K
57.36%-287K
49.39%-247K
33.60%-168K
74.43%-223K
38.98%-673K
After-tax profit from continuing operations
-201.87%-8.57M
-65.45%976K
955.08%8.41M
-32.06%2.83M
108.57%797K
188.51%5.62M
193.02%4.16M
353.68%3.03M
50.08%-9.3M
146.45%1.95M
After-tax profit from non-continuing business
----
----
204.37%9.1M
----
---8.72M
----
----
----
----
----
Special items of earning after tax
----
----
204.37%9.1M
----
---8.72M
----
----
----
----
----
Earning after tax
-148.92%-8.57M
-65.45%976K
321.02%17.51M
-32.06%2.83M
14.78%-7.92M
188.51%5.62M
193.02%4.16M
353.68%3.03M
50.08%-9.3M
146.45%1.95M
Profit attributable to shareholders
-148.92%-8.57M
-65.45%976K
321.02%17.51M
-32.06%2.83M
14.78%-7.92M
188.51%5.62M
193.02%4.16M
353.68%3.03M
50.08%-9.3M
146.45%1.95M
Basic earnings per share
-149.15%-0.029
-65.63%0.0033
310.71%0.059
-35.57%0.0096
15.15%-0.028
171.43%0.019
192.16%0.0149
351.16%0.0108
50.75%-0.033
146.67%0.007
Diluted earnings per share
-149.15%-0.029
-65.63%0.0033
310.71%0.059
-35.57%0.0096
15.15%-0.028
171.43%0.019
192.16%0.0149
351.16%0.0108
50.75%-0.033
146.67%0.007
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
--
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Turnover -3.56%77.85M-0.33%42.63M4.66%80.73M12.26%42.77M-10.45%77.13M-8.14%57.94M-9.82%38.1M-13.40%20M-12.79%86.13M-17.00%63.08M
Operating income -3.56%77.85M-0.33%42.63M4.66%80.73M12.26%42.77M-10.45%77.13M-8.14%57.94M-9.82%38.1M-13.40%20M-12.79%86.13M-17.00%63.08M
Operating expenses
Gross profit
Employee expense 5.05%-74.04M-7.39%-37.97M-19.06%-77.97M-7.79%-35.36M6.37%-65.49M4.32%-49.34M5.72%-32.81M16.08%-16.65M4.83%-69.95M6.65%-51.57M
Depreciation and amortization -1.20%-3.38M-110.01%-1.76M-59.25%-3.34M31.73%-839K44.69%-2.1M64.10%-1.76M62.87%-1.23M61.61%-645K59.40%-3.79M36.47%-4.91M
Special items of operating profit -189.05%-8.94M47.90%-1.85M226.41%10.04M-1,055.65%-3.56M61.03%-7.94M88.94%-427K117.58%372K121.55%531K38.59%-20.37M75.88%-3.86M
Operating profit -189.99%-8.5M-65.59%1.04M487.99%9.45M-32.04%3.01M120.14%1.61M133.82%6.42M119.12%4.44M460.49%3.23M53.74%-7.98M192.30%2.74M
Financing cost 51.89%-89K-408.33%-61K72.75%-185K60.00%-12K37.88%-679K-314.75%-506K74.36%-30K40.43%-28K-120.36%-1.09M-1.67%-122K
Earning before tax -192.75%-8.59M-67.49%976K898.28%9.26M-31.85%3M110.23%928K125.40%5.91M130.99%4.41M439.55%3.2M48.88%-9.07M184.77%2.62M
Tax 103.04%26K-----552.67%-855K28.34%-177K41.26%-131K57.36%-287K49.39%-247K33.60%-168K74.43%-223K38.98%-673K
After-tax profit from continuing operations -201.87%-8.57M-65.45%976K955.08%8.41M-32.06%2.83M108.57%797K188.51%5.62M193.02%4.16M353.68%3.03M50.08%-9.3M146.45%1.95M
After-tax profit from non-continuing business --------204.37%9.1M-------8.72M--------------------
Special items of earning after tax --------204.37%9.1M-------8.72M--------------------
Earning after tax -148.92%-8.57M-65.45%976K321.02%17.51M-32.06%2.83M14.78%-7.92M188.51%5.62M193.02%4.16M353.68%3.03M50.08%-9.3M146.45%1.95M
Profit attributable to shareholders -148.92%-8.57M-65.45%976K321.02%17.51M-32.06%2.83M14.78%-7.92M188.51%5.62M193.02%4.16M353.68%3.03M50.08%-9.3M146.45%1.95M
Basic earnings per share -149.15%-0.029-65.63%0.0033310.71%0.059-35.57%0.009615.15%-0.028171.43%0.019192.16%0.0149351.16%0.010850.75%-0.033146.67%0.007
Diluted earnings per share -149.15%-0.029-65.63%0.0033310.71%0.059-35.57%0.009615.15%-0.028171.43%0.019192.16%0.0149351.16%0.010850.75%-0.033146.67%0.007
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion------Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.------National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More